| 摘要 |
The present invention relates to a pharmaceutical composition exhibiting anticancer, anti-inflammatory, and antiviral activities containing one or more herb medicinal extracts selected from a group comprised of: (a) ginseng, Bupleurum falcatum, Anthriscus sylvestris (L.) Hoffm, Ostericum Koreanum, Aralia continentalis Kitagawa, aurantii fructus immaturus, Platycodonis Radix, Cnidium officinale Makino, Wolfiporia extensa, and licorice; and (b) Schizonepeta tenuifolia var. japonica (Maxim.) Kitag, Ledebouriella seseloides, Forsythia suspensa Vahl (Oleaceae), Lonicerae Flos, Agastachis Herba, Coptis japonica Makino, Scutellariae Radix, Scrophulariae Radix, Crataegi Fructus, and ginger. |
